Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats

Neuroscience

Volumn 165, Issue 3, 2010, Pages 850-862

  Meyers, B ^a   D'Agostino, A ^a   Walker, J ^a   Kritzer, M F ^a  

^a Stony Brook University   (United States)

Author keywords

androgen; depression anxiety; estrogen; indolamines; monoamines; schizophrenia

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANDROGEN; CATECHOL METHYLTRANSFERASE; DOPAMINE; ESTRADIOL; NORADRENALIN; SEROTONIN; SEX HORMONE; TESTOLACTONE; TESTOSTERONE PROPIONATE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CANCER ADJUVANT THERAPY; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME SPECIFICITY; FOREBRAIN; GONADECTOMY; HORMONAL REGULATION; HORMONE ACTION; HORMONE SUBSTITUTION; HYPOGONADISM; MALE; NEOSTRIATUM; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN METHYLATION; RAT; SYMPTOM;

AGING; ANIMALS; CATECHOL O-METHYLTRANSFERASE; CELL MEMBRANE; ESTRADIOL; HORMONE REPLACEMENT THERAPY; ISOENZYMES; MALE; MONOAMINE OXIDASE; NEOSTRIATUM; ORCHIECTOMY; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE PROPIONATE;

EID: 72749102924     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.11.013     Document Type: Article

References (124)

1. Adler A., Vescovo P., Robinson J.K., and Kritzer M.F. Gonadectomy in adult life increases tyrosine hydroxylase immunoreactivity in the prefrontal cortex and decreases open field activity in male rats. Neuroscience 89 (1999) 939-954
2. Alexander G.M., Swerdloff R.S., Wang C., Davidson T., McDonald V., Steiner B., and Hines M. Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm Behav 33 (1998) 85-94
3. Almeida O.P., Yeap B.B., Hankey G.J., Jamrozik K., and Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry 65 (2008) 283-289
4. Amore M., Scarlatti F., Quarta A.L., and Tagariello P. Partial androgen deficiency, depression and testosterone treatment in aging men. Aging Clin Exp Res 21 (2009) 1-8
5. Aubele T., Kaufman R., Montalmant F., and Kritzer M.F. Effects of gonadectomy and hormone replacement on a spontaneous novel object recognition task in adult male rats. Horm Behav 54 (2008) 244-252
6. Aubele T., Meyers B., Liu A., and Kritzer M.F. Gonadectomy in adult male rats increases extracellular dopamine levels in the prefrontal cortex: Possible causative role for effects on the norepinephrine transporter, but not the dopamine transporter or the enzyme catechol-O-methyltransferase. Abstract, Society for Neuroscience annual meeting (2008)
7. Barnett J.H., Heron J., Ring S.M., Golding J., Goldman D., Xu K., and Jones P.B. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry 164 (2007) 142-149
8. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23 (2002) 41-100
9. Bhatt S.D., and Dluzen D.E. Dopamine transporter function differences between male and female CD-1 mice. Brain Res 1035 (2005) 188-195
10. Biederman J., Kim J.W., Doyle A.E., Mick E., Fagerness J., Smoller J.W., and Faraone S.V. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr Genet 147B (2008) 1511-1518
11. Birgner C., Kindlundh-Hogberg A.M., Oreland L., Alsio J., Lindblom J., Schioth H.B., and Bergstrom L. Reduced activity of monoamine oxidase in the rat brain following repeated nandrolone decanoate administration. Brain Res 1219 (2008) 103-110
12. Boudikova B., Szumlanski C., Maidak B., and Weinshilboum R. Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48 (1990) 381-389
13. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., and van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262 (1993) 578-580
14. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Muller U., Aguet M., Babinet C., Shih J.C., et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268 (1995) 1763-1766
15. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., Taylor A., and Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 297 (2002) 851-854
16. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.M., Apud J., Egan M.F., Kleinman J.E., and Weinberger D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75 (2004) 807-821
17. Chen K., Cases O., Rebrin I., Wu W., Gallaher T.K., Seif I., and Shih J.C. Forebrain-specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure, and rescues aggressive behavior in monoamine oxidase A-deficient mice. J Biol Chem 282 (2007) 115-123
18. Cherrier M.M., Craft S., and Matsumoto A.H. Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J Androl 24 (2003) 568-576
19. Cherrier M.M., Matsumoto A.M., Amory J.K., Ahmed S., Bremner W., Peskind E.R., Raskind M.A., Johnson M., and Craft S. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 64 (2005) 290-296
20. Cherrier M.M., Rose A.L., and Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 170 (2003) 1808-1811
21. Chevillard C., Barden N., and Saavedra J.M. Estradiol treatment decreases type A and increases type B monoamine oxidase in specific brain stem areas and cerebellum of ovariectomized rats. Brain Res 222 (1981) 177-181
22. Cohn C.K., and Axelrod J. The effect of estradiol on catechol-O-methyltransferase activity in rat liver. Life Sci I 10 (1971) 1351-1354
23. Cosgrove K.P., Mazure C.M., and Staley J.K. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62 (2007) 847-855
24. Dalley J.W., Cardinal R.N., and Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28 (2004) 771-784
25. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148 (1991) 1474-1486
26. Denys D., Van Nieuwerburgh F., Deforce D., and Westenberg H. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol 16 (2006) 446-450
27. Dluzen D.E., Bhatt S., and McDermott J.L. Differences in reserpine-induced striatal dopamine output and content between female and male mice: implications for sex differences in vesicular monoamine transporter 2 function. Neuroscience 154 (2008) 1488-1496
28. Dluzen D.E., and McDermott J.L. Sex differences in dopamine- and vesicular monoamine-transporter functions. Ann NY Acad Sci 1139 (2008) 140-150
29. Domschke K., Freitag C.M., Kuhlenbaumer G., Schirmacher A., Sand P., Nyhuis P., Jacob C., Fritze J., Franke P., Rietschel M., Garritsen H.S., Fimmers R., Nothen M.M., Lesch K.P., Stogbauer F., and Deckert J. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol 7 (2004) 183-188
30. Ducci F., Newman T.K., Funt S., Brown G.L., Virkkunen M., and Goldman D. A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index. Mol Psychiatry 11 (2006) 858-866
31. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., and Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 6917-6922
32. Einon D. Spatial memory and response strategies in rats: age, sex and rearing differences in performance. Q J Exp Psychol 32 (1980) 473-489
33. Eley T.C., Tahir E., Angleitner A., Harriss K., McClay J., Plomin R., Riemann R., Spinath F., and Craig I. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am J Med Genet B Neuropsychiatr Genet 120B (2003) 90-96
34. Fahndrich E., Coper H., Christ W., Helmchen H., Muller-Oerlinghausen B., and Pietzcker A. Erythrocyte COMT-activity in patients with affective disorders. Acta Psychiatr Scand 61 (1980) 427-437
35. Fink G., Sumner B., Rosie R., Wilson H., and McQueen J. Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 105 (1999) 53-68
36. Fink G., Sumner B.E., Rosie R., Grace O., and Quinn J.P. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16 (1996) 325-344
37. Floderus Y., and Wetterberg L. The inheritance of human erythrocyte catechol-O-methyltransferase activity. Clin Genet 19 (1981) 392-395
38. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., and Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 95 (1998) 9991-9996
39. Goldberg T.E., Egan M.F., Gscheidle T., Coppola R., Weickert T., Kolachana B.S., Goldman D., and Weinberger D.R. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 60 (2003) 889-896
40. Goldberg T.E., and Weinberger D.R. Genes and the parsing of cognitive processes. Trends Cogn Sci 8 (2004) 325-335
41. Goldman-Rakic P.S. Cellular and circuit basis of working memory in prefrontal cortex of nonhuman primates. Prog Brain Res 85 (1990) 325-335 discussion:326-335
42. Goldman-Rakic P.S., Funahashi S., and Bruce C.J. Neocortical memory circuits. Cold Spring Harb Symp Quant Biol 55 (1990) 1025-1038
43. Goodman R., and Stevenson J. A twin study of hyperactivity-I. An examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires. J Child Psychol Psychiatry 30 (1989) 671-689
44. Guerra-Araiza C., Miranda-Martinez A., Neri-Gomez T., and Camacho-Arroyo I. Sex steroids effects on the content of GAD, TH, GABA(A), and glutamate receptors in the olfactory bulb of the male rat. Neurochem Res 33 (2008) 1568-1573
45. Gundlah C., Lu N.Z., and Bethea C.L. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 160 (2002) 271-282
46. Hallman J., Oreland L., Edman G., and Schalling D. Thrombocyte monoamine oxidase activity and personality traits in women with severe premenstrual syndrome. Acta Psychiatr Scand 76 (1987) 225-234
47. Harrison P.J., and Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 33 (2008) 3037-3045
48. Holschneider D.P., Kumazawa T., Chen K., and Shih J.C. Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat. Life Sci 63 (1998) 155-160
49. Huotari M., Santha M., Lucas L.R., Karayiorgou M., Gogos J.A., and Mannisto P.T. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice. J Pharmacol Exp Ther 303 (2002) 1309-1316
50. Janowsky J.S. The role of androgens in cognition and brain aging in men. Neuroscience 138 (2006) 1015-1020
51. Janowsky J.S., Chavez B., and Orwoll E. Sex steroids modify working memory. J Cogn Neurosci 12 (2000) 407-414
52. Jeong H., Kim M.S., Kim S.W., Kim K.S., and Seol W. Regulation of tyrosine hydroxylase gene expression by retinoic acid receptor. J Neurochem 98 (2006) 386-394
53. Ji J., McDermott J.L., and Dluzen D.E. Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice. J Neuroendocrinol 19 (2007) 725-731
54. Jiang H., Xie T., Ramsden D.B., and Ho S.L. Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology 45 (2003) 1011-1018
55. Kalsbeek A., de Bruin J.P., Matthijssen M.A., and Uylings H.B. Ontogeny of open field activity in rats after neonatal lesioning of the mesocortical dopaminergic projection. Behav Brain Res 32 (1989) 115-127
56. Karayiorgou M., Altemus M., Galke B.L., Goldman D., Murphy D.L., Ott J., and Gogos J.A. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A 94 (1997) 4572-4575
57. Karayiorgou M., Sobin C., Blundell M.L., Galke B.L., Malinova L., Goldberg P., Ott J., and Gogos J.A. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45 (1999) 1178-1189
58. Karoum F., Chrapusta S.J., and Egan M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63 (1994) 972-979
59. Kenny A.M., Bellantonio S., Gruman C.A., Acosta R.D., and Prestwood K.M. Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 57 (2002) M321-M325
60. Kessler J., and Markowitsch H.J. Delayed-alternation performance after kainic acid lesions of the thalamic mediodorsal nucleus and the ventral tegmental area in the rat. Behav Brain Res 3 (1981) 125-130
61. Kim J.J., Shih J.C., Chen K., Chen L., Bao S., Maren S., Anagnostaras S.G., Fanselow M.S., De Maeyer E., Seif I., and Thompson R.F. Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. Proc Natl Acad Sci U S A 94 (1997) 5929-5933
62. Kotler M., Barak P., Cohen H., Averbuch I.E., Grinshpoon A., Gritsenko I., Nemanov L., and Ebstein R.P. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet 88 (1999) 628-633
63. Kritzer M.F. Effects of acute and chronic gonadectomy on the catecholamine innervation of the cerebral cortex in adult male rats: insensitivity of axons immunoreactive for dopamine-beta-hydroxylase to gonadal steroids, and differential sensitivity of axons immunoreactive for tyrosine hydroxylase to ovarian and testicular hormones. J Comp Neurol 427 (2000) 617-633
64. Kritzer M.F., Adler A., Marotta J., and Smirlis T. Regionally selective effects of gonadectomy on cortical catecholamine innervation in adult male rats are most disruptive to afferents in prefrontal cortex. Cereb Cortex 9 (1999) 507-518
65. Kritzer M.F., Brewer A., Montalmant F., Davenport M., and Robinson J.K. Effects of gonadectomy on performance in operant tasks measuring prefrontal cortical function in adult male rats. Horm Behav 51 (2007) 183-194
66. Kritzer M.F., McLaughlin P.J., Smirlis T., and Robinson J.K. Gonadectomy impairs T-maze acquisition in adult male rats. Horm Behav 39 (2001) 167-174
67. Lachman H.M., Nolan K.A., Mohr P., Saito T., and Volavka J. Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155 (1998) 835-837
68. Lacreuse A. Effects of ovarian hormones on cognitive function in nonhuman primates. Neuroscience 138 (2006) 859-867
69. Landry M., and Di Paolo T. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. Brain Res Mol Brain Res 112 (2003) 82-89
70. Le Saux M., and Di Paolo T. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. J Psychiatry Neurosci 30 (2005) 110-117
71. Le Saux M., and Di Paolo T. Influence of oestrogenic compounds on monoamine transporters in rat striatum. J Neuroendocrinol 18 (2006) 25-32
72. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., and Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
73. Lu P.H., Masterman D.A., Mulnard R., Cotman C., Miller B., Yaffe K., Reback E., Porter V., Swerdloff R., and Cummings J.L. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol 63 (2006) 177-185
74. Luine V.N. Sex steroids and cognitive function. J Neuroendocrinol 20 (2008) 866-872
75. Luine V.N., Khylchevskaya R.I., and McEwen B.S. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res 86 (1975) 293-306
76. Luine V.N., and Rhodes J.C. Gonadal hormone regulation of MAO and other enzymes in hypothalamic areas. Neuroendocrinology 36 (1983) 235-241
77. Lundstrom K., Tenhunen J., Tilgmann C., Karhunen T., Panula P., and Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1251 (1995) 1-10
78. Mani S.K., Portillo W., and Reyna A. Steroid hormone action in the brain: cross-talk between signalling pathways. J Neuroendocrinol 21 (2009) 243-247
79. Matsumoto M., Weickert C.S., Beltaifa S., Kolachana B., Chen J., Hyde T.M., Herman M.M., Weinberger D.R., and Kleinman J.E. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 28 (2003) 1521-1530
80. Meyers B., and Kritzer M.F. In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex. Neuroscience 159 (2009) 271-282
81. Morrow B.A., Roth R.H., and Elsworth J.D. TMT, a predator odor, elevates mesoprefrontal dopamine metabolic activity and disrupts short-term working memory in the rat. Brain Res Bull 52 (2000) 519-523
82. Murphy B.L., Arnsten A.F., Goldman-Rakic P.S., and Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A 93 (1996) 1325-1329
83. Nilsson K.W., Sjoberg R.L., Damberg M., Leppert J., Ohrvik J., Alm P.O., Lindstrom L., and Oreland L. Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biol Psychiatry 59 (2006) 121-127
84. Ortega-Corona B.G., Valencia-Sanchez A., Kubli-Garfias C., Anton-Tay F., Salazar L.A., Villarreal J.E., and Ponce-Monter H. Hypothalamic monoamine oxidase activity in ovariectomized rats after sexual behavior restoration. Arch Med Res 25 (1994) 337-340
85. Ou X.M., Chen K., and Shih J.C. Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem 281 (2006) 21512-21525
86. Paxinos G., and Watson C. The rat brain in sterotaxic coordinates. 4th ed. (1998), Academic Press, New York
87. Pecins-Thompson M., Brown N.A., Kohama S.G., and Bethea C.L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 16 (1996) 7021-7029
88. Philippu G., Hoo J.J., Milech U., Argarwall D.P., Schrappe O., and Goedde H.W. Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychoses. Psychiatry Res 4 (1981) 139-146
89. Pooley E.C., Fineberg N., and Harrison P.J. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Mol Psychiatry 12 (2007) 556-561
90. Poyurovsky M., Michaelovsky E., Frisch A., Knoll G., Amir I., Finkel B., Buniak F., Hermesh H., and Weizman R. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study. Neurosci Lett 389 (2005) 21-24
91. Redmond Jr. D.E., Baulu J., Murphy D.L., Loriaux D.L., Zeigler M.G., and Lake C.R. The effects of testosterone on plasma and platelet monoamine oxidase (MAO) an plasma dopamine-beta-hydroxylase (DBH) activities in the male rhesus monkey. Psychosom Med 38 (1976) 315-326
92. Rothe C., Koszycki D., Bradwejn J., King N., Deluca V., Tharmalingam S., Macciardi F., Deckert J., and Kennedy J.L. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology 31 (2006) 2237-2242
93. Saito T., Lachman H.M., Diaz L., Hallikainen T., Kauhanen J., Salonen J.T., Ryynanen O.P., Karvonen M.K., Syvalahti E., Pohjalainen T., Hietala J., and Tiihonen J. Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res 109 (2002) 113-119
94. Salih S.M., Jamaluddin M., Salama S.A., Fadl A.A., Nagamani M., and Al-Hendy A. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome. Fertil Steril 89 (2008) 1414-1421
95. Salminen E., Portin R., Korpela J., Backman H., Parvinen L.M., Helenius H., and Nurmi M. Androgen deprivation and cognition in prostate cancer. Br J Cancer 89 (2003) 971-976
96. Salminen E.K., Portin R.I., Koskinen A.I., Helenius H.Y., and Nurmi M.J. Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer 103 (2005) 1381-1387
97. Seeman M.V., and Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 16 (1990) 185-194
98. Serova L.I., Maharjan S., Huang A., Sun D., Kaley G., and Sabban E.L. Response of tyrosine hydroxylase and GTP cyclohydrolase I gene expression to estrogen in brain catecholaminergic regions varies with mode of administration. Brain Res 1015 (2004) 1-8
99. Shih J.C. Molecular basis of human MAO A and B. Neuropsychopharmacology 4 (1991) 1-7
100. Shih J.C., Chen K., and Ridd M.J. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22 (1999) 197-217
101. Shores M.M., Moceri V.M., Sloan K.L., Matsumoto A.M., and Kivlahan D.R. Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry 66 (2005) 7-14
102. Shores M.M., Sloan K.L., Matsumoto A.M., Moceri V.M., Felker B., and Kivlahan D.R. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 61 (2004) 162-167
103. Simerly R.B. Hormonal control of the development and regulation of tyrosine hydroxylase expression within a sexually dimorphic population of dopaminergic cells in the hypothalamus. Brain Res Mol Brain Res 6 (1989) 297-310
104. Sjoberg R.L., Ducci F., Barr C.S., Newman T.K., Dell'osso L., Virkkunen M., and Goldman D. A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuropsychopharmacology 33 (2008) 425-430
105. Sjoberg R.L., Nilsson K.W., Wargelius H.L., Leppert J., Lindstrom L., and Oreland L. Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors. Am J Med Genet B Neuropsychiatr Genet 144B (2007) 159-164
106. Stein M.B., Fallin M.D., Schork N.J., and Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology 30 (2005) 2092-2102
107. Strous R.D., Bark N., Woerner M., and Lachman H.M. Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41 (1997) 493-495
108. Strous R.D., Nolan K.A., Lapidus R., Diaz L., Saito T., and Lachman H.M. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet B Neuropsychiatr Genet 120B (2003) 29-34
109. Tassin J.P., Stinus L., Simon H., Blanc G., Thierry A.M., Le Moal M., Cardo B., and Glowinski J. Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res 141 (1978) 267-281
110. Tees R.C., Midgley G., and Nesbit J.C. The effect of early visual experience on spatial maze learning in rats. Dev Psychobiol 14 (1981) 425-438
111. Tenhunen J., Salminen M., Jalanko A., Ukkonen S., and Ulmanen I. Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. DNA Cell Biol 12 (1993) 253-263
112. Thanky N.R., Son J.H., and Herbison A.E. Sex differences in the regulation of tyrosine hydroxylase gene transcription by estrogen in the locus coeruleus of TH9-LacZ transgenic mice. Brain Res Mol Brain Res 104 (2002) 220-226
113. Turvin J.C., Messer Jr. W.S., and Kritzer M.F. On again, off again effects of gonadectomy on the acoustic startle reflex in adult male rats. Physiol Behav 90 (2007) 473-482
114. van Haaren F., van Hest A., and Heinsbroek R.P. Behavioral differences between male and female rats: effects of gonadal hormones on learning and memory. Neurosci Biobehav Rev 14 (1990) 23-33
115. Verma A., and Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16 (1996) 373-379
116. Volavka J., Bilder R., and Nolan K. Catecholamines and aggression: the role of COMT and MAO polymorphisms. Ann NY Acad Sci 1036 (2004) 393-398
117. Westerink B.H., and Spaan S.J. Simultaneous determination of the formation rate of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in various rat brain areas. Brain Res 252 (1982) 239-245
118. Widom C.S., and Brzustowicz L.M. MAOA and the "cycle of violence": childhood abuse and neglect, MAOA genotype, and risk for violent and antisocial behavior. Biol Psychiatry 60 (2006) 684-689
119. Woo J.M., Yoon K.S., Choi Y.H., Oh K.S., Lee Y.S., and Yu B.H. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J Psychiatr Res 38 (2004) 365-370
120. Xie T., Ho S.L., and Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56 (1999) 31-38
121. Yavich L., Forsberg M.M., Karayiorgou M., Gogos J.A., and Mannisto P.T. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 27 (2007) 10196-10209
122. Yin P.H., Lee H.C., Chau G.Y., Liu T.Y., Liu H.C., Lui W.Y., and Chi C.W. Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females. Cancer Lett 212 (2004) 195-201
123. Zahrt J., Taylor J.R., Mathew R.G., and Arnsten A.F. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17 (1997) 8528-8535
124. Zurcher G., and Da Prada M. Rapid and sensitive single-step radiochemical assay for catechol-O-methyltransferase. J Neurochem 38 (1982) 191-195